Immobilized DNase I and application thereof in nucleic acid removal
By immobilizing DNase I with sodium alginate, the problems of low nucleic acid removal efficiency and nuclease contamination in biological products are solved, and efficient and specific nucleic acid removal is achieved. It is suitable for the production of biological agents and provides a safe and reliable method.
Patent Information
- Application Number
- CN202411335523.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-24
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art is difficult to completely eliminate small or high-expressed nucleic acid contamination in biological products during the removal of nucleic acid in biological products, especially when DNA residue requirements are high, the removal rate of anion exchange chromatography is insufficient, and the treatment is based on restriction nuclease. It is long and may introduce free nucleic acid contamination.
The enzyme immobilization technology was used to mix DNase I with sodium alginate and harden it in CaCl2 solution to prepare immobilized DNase I for nucleic acid removal, which solved the problem of secondary contamination of nuclease and improved the removal efficiency.
Immobilized DNase Ⅰ removal efficiency reaches 99.99% within ten minutes, with good specificity and stability, expanding the applicable pH and temperature range of enzymes, avoiding contamination caused by free nucleases, and is suitable for nucleic acid removal of biological agents. .
Smart Images

Figure CN119082084A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology, and particularly relates to the application of immobilized DNase I in nucleic acid removal. Background Art
[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] Biological preparations such as vaccines refer to biological products that have the function of preventing, treating, and diagnosing corresponding infectious diseases or other related diseases. They are formed by processing microorganisms such as bacteria, rickettsia, viruses, and their metabolites. As the main raw material for the production of biological preparations, the quality of the cell matrix is crucial to the production of biological products such as vaccines, for example, it has an important impact on the quality, yield, and safety of its products. Cellular DNA exists in the cell matrix as a potential risk factor. In order to ensure that biological products have extremely high quality and safety, they must be strictly controlled in terms of quality. First of all, the raw materials need to be screened and tested to ensure that they meet the quality standards and are free of potential contaminants. During the production process, a series of operations and monitoring steps need to be strictly implemented to ensure the purity and stability of the cell matrix. In addition, effective methods and technologies need to be used to remove or kill potential viral infections and cell residues, and to effectively remove residual DNA. The quality control of biological products is a comprehensive and complex process involving various links and aspects.
[0004] Nowadays, anion exchange chromatography is a commonly used technology in the process of removing nucleic acids from biological products. Although this technology can remove some nucleic acids, it cannot completely eliminate the contamination of smaller or highly expressed nucleic acids, which restricts the large-scale production of biological products. The principle of anion exchange chromatography is based on the interaction between negatively charged molecules in the sample and positively charged functional groups fixed on the chromatography column, thereby achieving the removal of negatively charged substances in the sample. Although anion exchange chromatography has a relatively wide range of applications, when the requirements for the residual DNA in biological preparations are high, it is difficult to meet the requirements using anion chromatography. For example, when using molecular sieves for nucleic acid removal, the removal rate of nucleic acids is only 80%, which is difficult to meet the requirements.
[0005] Some methods for removing biological agents based on restriction nucleases have been widely used in various industries such as pharmaceutical and bioengineering production. For example, Cui et al. used Benzonase non-restriction endonuclease to remove nucleic acids from vero cells, which can reduce the nucleic acid in the sample from 300 ng / mL to 0.9 ng / mL, and the nucleic acid removal efficiency reached 98%. However, the processing time of this technology is two hours, which is too long to meet the requirements of the biological agent production process. In addition, the addition of free nucleases also creates new pollution for biological agents.
[0006] Studies have shown that sodium alginate immobilized enzyme is an efficient enzyme immobilization method, but there is no research on immobilizing DNase Ⅰ. Summary of the invention
[0007] In order to solve the above problems, the present invention provides the application of immobilized DNase I in nucleic acid removal. The present invention uses enzyme immobilization technology to immobilize DNase I, thereby solving the problem of secondary nuclease contamination caused by the application of DNase I. The nucleic acid removal efficiency of immobilized DNase I reaches 99.99% within ten minutes. And the technology has good specificity.
[0008] In order to achieve the above object, the present invention adopts the following technical solution:
[0009] The first aspect of the present invention provides a method for preparing immobilized DNase I, comprising:
[0010] Mix DNase I solution and sodium alginate in a ratio of 1:4-6 to obtain a mixed solution;
[0011] The mixed solution is made into beads, and then added into a CaCl2 solution, and allowed to stand to harden.
[0012] In some embodiments, the mixing is performed by vortexing.
[0013] In some embodiments, the particle size of the beads is 1-2 mm.
[0014] In some embodiments, the concentration of the CaCl2 solution is 0.2-0.3M.
[0015] In some embodiments, the temperature of the static state is 4-5°C
[0016] In some embodiments, the standing time is 2-3 hours.
[0017] The second aspect of the present invention provides immobilized DNase I prepared by the above method.
[0018] The third aspect of the present invention provides the use of the above-mentioned immobilized DNase I in nucleic acid removal.
[0019] In some embodiments, the nucleic acid includes: sul1, 16SrRNA.
[0020] In some embodiments, the treatment conditions are: pH 7-8, temperature 20-30°C or 25°C.
[0021] Beneficial Effects of the Invention
[0022] (1) The nucleic acid removal efficiency of the immobilized DNase I of the present invention reaches 99.99% within ten minutes, and has good specificity.
[0023] (2) Currently, enzyme immobilization methods mainly include four methods: adsorption method, embedding method, covalent bond method, and cross-linking method. The present invention has found that compared with other methods, the use of sodium alginate to immobilize nuclease can increase the stability and reusability of nuclease to a certain extent, solve the secondary pollution problem caused by the use of free nuclease, and thus provide a safer and more reliable method for the removal of nucleic acids in biological preparations.
[0024] (3) The efficiency of nucleic acid removal by immobilized DNase I of the present invention does not decrease significantly, and the pH and temperature ranges of the immobilized nuclease are wider. At the same time, the preparation method of the present invention is simple, highly practical, and easy to promote. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] The accompanying drawings constituting a part of the present invention are used to provide a further understanding of the present invention, and the exemplary embodiments of the present invention and their description are used to explain the present invention and do not constitute improper limitations on the present invention.
[0026] Figure 1 This is the change before and after sul1 is treated with DNase I in the present invention;
[0027] Figure 2 The changes before and after DNase I treatment of 16SrRNA in the present invention;
[0028] Figure 3 The effect of pH on the nucleic acid removal efficiency of DNase I after immobilization in the present invention, (a) the nucleic acid removal efficiency of DNase I at different pH; (b) the change of nucleic acid concentration at different pH;
[0029] Figure 4 The effect of temperature on the nucleic acid removal efficiency of DNase I after immobilization in the present invention, (a) the nucleic acid removal efficiency of DNase I at different temperatures; (b) the change of nucleic acid concentration at different temperatures. DETAILED DESCRIPTION
[0030] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used in the present invention have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0031] The present invention will be further described in detail below in conjunction with specific embodiments. It should be noted that the specific embodiments are intended to explain the present invention rather than to limit it.
[0032] Example 1
[0033] The immobilization method is as follows: DNase I solution and sodium alginate with a mass concentration of 2% are mixed in a ratio of 1:4, and the mixture is dissolved evenly using a vortex oscillator. The mixed solution is used to generate beads with a diameter of about 1 mm using a syringe, and placed in a 0.2M CaCl2 solution at 4°C for 2 hours to harden. The DNase I content in the solution before and after immobilization is measured to determine the DNase I immobilization yield.
[0034] Example 2
[0035] 1 mg of the immobilized DNase I prepared in Example 1 was used for the experiment to explore the effects of temperature and pH on its removal efficiency.
[0036] qPCR was used to detect changes in nucleic acid before and after treatment, wherein the qPCR system and primers used are shown in Table 1, and the qPCR reaction system is shown in Table 2.
[0037] Table 1. Primers
[0038]
[0039] Table 2. qPCR system
[0040]
[0041] Coefficient calibration
[0042] (1) Nucleic acid removal efficiency and specificity:
[0043] The present invention uses DNase I to treat sul1 and 16SrRNA in the sample to verify its efficiency and specificity. The present invention uses DNase I to conduct an experiment for 1 hour, and a sample is taken every 10 minutes. Figure 1 It can be seen from the figure that after DNase I treatment, the concentration of sul1 in the sample gradually decreased. Within 10 minutes, the concentration of sul1 increased from 2.63±0.03×10 12The number of copies / mL was reduced to 10 7 At 60 min, the concentration of sul1 in the sample dropped to 10 5 copies / mL, which is close to the environmental level. This shows that DNase I has a good removal effect on sul1 in the sample. On the other hand, the present invention uses DNase I to treat 16SrRNA to verify its specificity. The results are shown in Figure 2 It was shown that in the samples treated with DNase, the copy number of 16SrRNA was basically unchanged, and maintained a copy number close to the initial nucleic acid level within 60 minutes. This shows that DNase I has good specificity and can selectively degrade DNA molecules. Through the above experiments, the present invention proves the effectiveness and reliability of DNase I in sample processing. In addition, the activity of nuclease is not reduced after immobilization, and the new contamination caused by free nuclease is solved, which provides a means for the nonspecific removal of DNA in biological preparations. In addition, it provides a new idea for the removal of nucleic acid contamination in genetic testing technology.
[0044] (2) Effect of temperature and pH on removal efficiency:
[0045] Temperature is an important factor affecting enzyme activity. This paper investigates the effect of pH on the activity of DNase I after sodium alginate immobilization. The optimal pH value for DNase I in the free state is 7-8. When the pH value of immobilized DNase I is 7 or 8, the nucleic acid removal efficiency is maintained at the highest level. The concentration of sul1 is increased from 2.63±0.03×10 12 The copies / mL was reduced to 10 7 copies / mL, and the removal efficiency reached more than 99.99%. When the pH was 6 and 10, the nucleic acid removal efficiency decreased, and the concentration of sul1 increased from 2.13±0.56×10 11 copies / mL, 2.41±0.90×10 11 The copies / mL was reduced to 2.22±0.51×10 9 copies / mL, 2.24±0.24×10 10 The nucleic acid removal efficiency reached 98.96±0.24% and 89.95±10.55% respectively. When the pH value was 2, 4, and 12, the removal efficiency was further reduced, and the concentration of sul1 was reduced from 3.65±1.24×10 11 copies / mL, 1.39±0.06×10 11 copies / mL, 3.51±0.83×10 11The copies / mL was reduced to 2.95±0.67×10 11 copies / mL, 7.75±0.20×10 10 copies / mL, 1.63±0.59×10 11 copies / mL. The nucleic acid removal efficiencies were 19.17±18.34%, 44.28±14.44%, and 53.60±16.66%, respectively.
[0046] In addition, temperature is also one of the important factors affecting enzyme activity. Among them, the optimal action temperature of free DNase I is 37°C. Here, the present invention explores the efficiency of immobilized nuclease at different temperatures. From the results, it can be seen that the optimal action temperature of immobilized DNase I is 25°C, and within 10 minutes, the concentration of sul1 can be increased from 2.63±0.03×10 12 The copies / mL was reduced to 1.37±0.21×10 7 copies / mL, and the removal efficiency reached 99.99%. When the temperature was 4℃, 37℃, 50℃, and 60℃, the efficiency of nucleic acid was slightly reduced, and the concentration of sul1 could be increased from 2.38±0.69×10 11 copies / mL decreased to 4.58±1.35×10 8 copies / mL, 1.34±0.60×10 8 copies / mL, 4.55±0.69×10 7 copies / mL, 4.29±1.62×10 7 copies / mL, and the removal efficiencies were 99.80±0.06%, 99.94±0.02%, 99.98±0.002%, and 99.98±0.006%, respectively.
[0047] In summary, the removal efficiency of nucleic acid after immobilization did not decrease significantly, and the pH and temperature range of the immobilized nuclease were wider. Therefore, it is feasible to use immobilized DNase I to remove DNA from samples.
[0048] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for preparing immobilized DNase I, characterized in that: include: Mix DNaseⅠ solution and sodium alginate in a ratio of 1:4-6 to obtain a mixed solution; The mixed solution is made into beads, and then added into a CaCl2 solution, and allowed to stand to harden.
2. The method for immobilizing DNase I according to claim 1, characterized in that: The mixing was performed by vortexing.
3. The method for immobilizing DNase I according to claim 1, characterized in that: The particle size of the condensed beads is 1-2 mm.
4. The method for immobilizing DNase I according to claim 1, characterized in that: The concentration of the CaCl2 solution is 0.2-0.3M.
5. The method for immobilizing DNase I according to claim 1, characterized in that: The standing temperature is 4-5°C.
6. The method for immobilizing DNase I according to claim 1, characterized in that: The standing time is 2-3h.
7. Immobilized DNase I prepared by the method according to any one of claims 1 to 6.
8. Use of the immobilized DNase I as claimed in claim 7 in nucleic acid removal.
9. The use according to claim 8, characterized in that The nucleic acid includes: sul1, 16SrRNA.
10. The use according to claim 8, characterized in that The treatment conditions are: pH value is 7-8, temperature is 20-30℃ or 25℃.
